Publication


Featured researches published by Federica Cavallo.


Clinical Lymphoma, Myeloma & Leukemia | 2006

Response to bortezomib and activation of osteoblasts in multiple myeloma.

Maurizio Zangari; Shmuel Yaccoby; Federica Cavallo; Dixie Lee Esseltine; Guido Tricot


American Journal of Hematology | 2007

Predictive value of alkaline phosphatase for response and time to progression in bortezomib‐treated multiple myeloma patients

Maurizio Zangari; Dixie-Lee Esseltine; Federica Cavallo; Rachel Neuwirth; Francesca Elice; Michael J. Burns; Shmuel Yaccoby; Paul G. Richardson; Pieter Sonneveld; Guido Tricot


American Journal of Hematology | 2007

Hyperammonemia and encephalopathy in patients with multiple myeloma.

Giampaolo Talamo; Federica Cavallo; Maurizio Zangari; Bart Barlogie; Choon-Kee Lee; Mauricio Pineda-Roman; Elias Kiwan; Somashekar G. Krishna; Guido Tricot


Blood | 2008

Parathyroid Hormones (PTH) Serum Variations Are Associated with Bortezomib Response in Multiple Myeloma Patients

Maurizio Zangari; Lisa Pappas; Fenghuang Zhan; Naveen Sanath Kumar; Federica Cavallo; Larry J. Suva; Guido Tricot; Dixie-Lee Esseltine; Shmuel Yaccoby


Blood | 2006

Erythropoietin Therapy and Venous Thromboembolic Events in Patients with Multiple Myeloma Receiving Chemotherapy with or without Thalidomide.

Maurizio Zangari; Federica Cavallo; Keshava Prasad; Louis M. Fink; Sharon K. Coon; Bart Barlogie; Guido Tricot


5th ESLHO symposium | 2016

First comparison between Multicolor Flow Cytometry and droplet digital PCR for tumor burden quantification at baseline in mantle cell lymphoma

Daniela Drandi; Cristina Jiménez; Luigia Monitillo; Daniela Barbero; Marina Ruggeri; Barbara Mantoan; Elisa Genuardi; Milena Gilestro; Zaccaria,Gian, Maria; Paola Ghione; M Vasta; M Loschirico; Paola Omedè; Federica Cavallo; Sergio Cortelazzo; Mario Boccadoro; Ramón García-Sanz; Marco Ladetto; Simone Ferrero


Archive | 2013

multiple myeloma: updated results of a randomized controlled trial Oral melphalan, prednisone, and thalidomide in elderly patients with

Pellegrino Musto; Michele Cavo; Fausto Dore; Federica Cavallo; Patrizia Falco; Giovannino Ciccone; Marco Montanaro; Roberto Ria; Antonio Capaldi; Renato Zambello; Giulia Benevolo; Daniele Antonio Palumbo; Sara Bringhen; Anna Marina Liberati; Tommaso Caravita; Antonietta Falcone


Archive | 2013

and is an independent predictor of poor outcome Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma

Paola Omedè; Antonio Palumbo; Mario Boccadoro; Alberto Rocci; Monica Astolfi; Mara Compagno; Sara Mariani; Laura Godio; Lydia Marino; Barbara Mantoan; Beata Bode-Lesniewska; Gloria Pagliano; Roberto Francese; Loredana Santo; Daniela Drandi; Alessandra Bertola; Patrizia Falco; Federica Cavallo; Irene Ricca; Marco Ladetto; Sonia Vallet; Andreas Trojan; Luigia Monitillo; Rosalba Rosato


Archive | 2013

aged 50 to 70: results of a randomized controlled trial Intermediate-dose melphalan improves survival of myeloma patients

E Pogliani; Anna Marina Liberati; Franco Dammacco; Giovannino Ciccone; Mario; Federica Cavallo; Patrizia Falco; Cecilia Rus; Massimo Massaia; Franco Mandelli; Tommasina Guglielmelli; Mariella Grasso; Vincenzo Callea; Alessandra Bertola; Vito Michele Lauta; Cesare Bergonzi; Anna Maria Barbui; Tommaso Caravita; Antonio Capaldi; Antonio Palumbo; Sara Bringhen; Maria Teresa Petrucci; Pellegrino Musto; Fausto Rossini


Archive | 2013

myeloma? Have drug combinations supplanted stem cell transplantation in

Antonio Palumbo; Federica Cavallo

Researchain Logo
Decentralizing Knowledge